Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Cancer Cell Année : 2020

Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response

Wendy Beguelin
  • Fonction : Auteur correspondant
Ari M. Melnick
  • Fonction : Auteur correspondant

Résumé

Follicular lymphomas (FLs) are slow-growing, indolent tumors containing extensive follicular dendritic cell (FDC) networks and recurrent EZH2 gain-of-function mutations. Paradoxically, FLs originate from highly proliferative germinal center (GC) B cells with proliferation strictly dependent on interactions with T follicular helper cells. Herein, we show that EZH2 mutations initiate FL by attenuating GC B cell requirement for T cell help and driving slow expansion of GC centrocytes that become enmeshed with and dependent on FDCs. By impairing T cell help, mutant EZH2 prevents induction of proliferative MYC programs. Thus, EZH2 mutation fosters malignant transformation by epigenetically reprograming B cells to form an aberrant immunological niche that reflects characteristic features of human FLs, explaining how indolent tumors arise from GC B cells.

Domaines

Cancer

Dates et versions

hal-02797079 , version 1 (05-06-2020)

Identifiants

Citer

Wendy Beguelin, Matt Teater, Cem Meydan, Kenneth B. Hoehn, Jude M. Phillip, et al.. Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response. Cancer Cell, 2020, 37 (5), pp.655-+. ⟨10.1016/j.ccell.2020.04.004⟩. ⟨hal-02797079⟩
55 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More